Plasma Cell Dyscrasias
Bart Barlogie
Abstract
Bart Barlogie
Abstract
PLASMA cell dyscrasias refer to a spectrum of disorders characterized by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow and, sometimes, tissue deposition of monoclonal immunoglobulins or their components (Table 21-1). The disorders include multiple myeloma (MM) and Waldenström's macroglobulinemia, as well as rare conditions such as light-chain deposition disease (LCDD) and heavy-chain diseases (HCDs). Amyloidosis refers to a group of tissue deposition disorders, among which light-chain amyloidosis is a plasma cell dyscrasia. Monoclonal gammopathy of undetermined significance is an asymptomatic laboratory deviation that may evolve into one of the previously mentioned diseases. MULTIPLE MYELOMA Multiple myeloma is the most serious and prevalent plasma cell dyscrasia, affecting approximately four of 100 000 Americans each year (Table 21-2). The median age at onset is 60 years, and black persons are affected twice as often as white persons. Symptoms usually result from lytic bone disease, anemia, renal failure, and immunodeficiency.
OpenAlex reports 73 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
PLASMA cell dyscrasias refer to a spectrum of disorders characterized by the monoclonal proliferation of lymphoplasmacytic cells in the bone marrow and, sometimes, tissue deposition of monoclonal immunoglobulins or their components (Table 21-1). The disorders include multiple myeloma (MM) and Waldenström's macroglobulinemia, as well as rare conditions such as light-chain deposition disease (LCDD) and heavy-chain diseases (HCDs). Amyloidosis refers to a group of tissue deposition disorders, among which light-chain amyloidosis is a plasma cell dyscrasia. Monoclonal gammopathy of undetermined significance is an asymptomatic laboratory deviation that may evolve into one of the previously mentioned diseases. MULTIPLE MYELOMA Multiple myeloma is the most serious and prevalent plasma cell dyscrasia, affecting approximately four of 100 000 Americans each year (Table 21-2). The median age at onset is 60 years, and black persons are affected twice as often as white persons. Symptoms usually result from lytic bone disease, anemia, renal failure, and immunodeficiency.
Key concepts: Medicine, Dyscrasia, Plasma cell, Paraproteinemias, Dermatology, Internal medicine, Immunology, Multiple myeloma